Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on February 20, 2003; DOI 10.1182/blood-2002-09-2799.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-09-2799v1
101/12/4733    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugiyama, D.
Right arrow Articles by Tsuji, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugiyama, D.
Right arrow Articles by Tsuji, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted September 30, 2002
Accepted January 21, 2003

Erythropoiesis from acetyl LDL incorporating endothelial cells at the pre-liver stage

Daisuke Sugiyama*, Minetaro Ogawa, Imiko Hirose, Thierry Jaffredo, Ken-ichi Arai, and Kohichiro Tsuji

Division of Molecular and Developmental Biology, Department of Basic Medical Science, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Division of Cellular Therapy, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Department of Cell Differentiation, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto, Japan
Developmental Biology Unit, University Pierre and Marie Curie, Paris, France

* Corresponding author; email: Daisuke.Sugiyama{at}snv.jussieu.fr.

Erythropoiesis is characterized by two distinct waves of production during mouse embryogenesis: a primitive one originating from the yolk sac (YS) and a definitive one produced from both the YS and the embryo proper. How this last wave is generated remains unclear. We put forward the hypothesis that erythroid cells could be generated by endothelial cells (ECs). To investigate this problem in depth, we have designed a method to label ECs at 10 days post-coitum. This label associates two techniques: an intracardiac inoculation that allows molecules to be delivered into the blood stream, followed by a whole embryo culture period. DiI-conjugated acetylated low-density lipoproteins (Ac-LDL-DiI) was used to specifically tag ECs from the inside. One hour after inoculation, DiI staining was found along the entire endothelial tree. FACS analysis revealed that DiI+ cells were CD31+, CD34+ and CD45-, an antigen make-up characteristic for the endothelial lineage. Twelve hours after inoculation, 43% of DiI+ circulating cells belonged to the erythroid lineage. These cells expressed Ter 119 and displayed an adult globin chain arrangement, thus belonged to the definitive lineage as confirmed in erythroid colony formation. The rest of the cells likely represent committed white blood cells or multi-potent progenitors as revealed by a mix-colony formation. Beyond the 29-somite stage, the proportion of the DiI+ erythroid cells gradually decreased. These results demonstrate, for the first time in the mouse embryo, the generation of hematopoietic cells from an endothelial intermediate, using an in vivo tracing. We thus provide evidence for a release of these cells into the circulation and put forward the hypothesis that these cells are able to colonize the fetal liver and generate definitive erythrocytes in vivo.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
J. Y. Bertrand, A. D. Kim, S. Teng, and D. Traver
CD41+ cmyb+ precursors colonize the zebrafish pronephros by a novel migration route to initiate adult hematopoiesis
Development, May 15, 2008; 135(10): 1853 - 1862.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Shinoda, K. Umeda, T. Heike, M. Arai, A. Niwa, F. Ma, H. Suemori, H. Y. Luo, D. H. K. Chui, R. Torii, et al.
{alpha}4-Integrin+ endothelium derived from primate embryonic stem cells generates primitive and definitive hematopoietic cells
Blood, March 15, 2007; 109(6): 2406 - 2415.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Zhou, P. D. Acton, and V. A. Ferrari
Imaging Stem Cells Implanted in Infarcted Myocardium
J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2094 - 2106.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
H. K. A. Mikkola and S. H. Orkin
The journey of developing hematopoietic stem cells.
Development, October 1, 2006; 133(19): 3733 - 3744.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
G. Dai, H. Sakamoto, Y. Shimoda, T. Fujimoto, S.-I. Nishikawa, and M. Ogawa
Over-expression of c-Myb increases the frequency of hemogenic precursors in the endothelial cell population.
Genes Cells, August 1, 2006; 11(8): 859 - 870.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Sakamoto, G. Dai, K. Tsujino, K. Hashimoto, X. Huang, T. Fujimoto, M. Mucenski, J. Frampton, and M. Ogawa
Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development
Blood, August 1, 2006; 108(3): 896 - 903.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
C. Pouget, R. Gautier, M.-A. Teillet, and T. Jaffredo
Somite-derived cells replace ventral aortic hemangioblasts and provide aortic smooth muscle cells of the trunk
Development, March 15, 2006; 133(6): 1013 - 1022.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. V. Frangioni and R. J. Hajjar
In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease
Circulation, November 23, 2004; 110(21): 3378 - 3383.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020